20 October 2025
| Judith Cave, Nina Bainbridge
|
EYE - General
Supporting and retaining the workforce is a top priority for all NHS organisations, but it’s not clear how best to do this, or how such support should be funded. Junior doctors have clinical and educational supervision, and the quality of...
One week into my first year as a doctor, buried under a mountain of ward jobs, night shifts and the sheer vertical learning curve of FY1, I decided to challenge myself further: I booked the FRCOphth Part 1 exam. The...
Government announces drive to digitise GP phonelines and offer greater options in patient access to care in dentistry and pharmacy, but does not capitalise on opportunities to improve patient experiences closer to home or address IT connectivity issues holding back optometry services.
Risk assessment of post-LASIK corneal ectasia in refractive surgery patients is now a more exact, objective, evaluation thanks to the work of Heidelberg Engineering and a leading research partner in Paris.
The Association of British Dispensing Opticians (ABDO) has given the go ahead for contact lens opticians to prescribe a groundbreaking new therapy, enabling ~1,700 new practitioners to offer the treatment to their patients. NuVision Biotherapies, a UK based tissue-therapy company...
Glaucoma UK is delighted to announce the three recipients of our 2025 project grants. The panel had a difficult time deciding between some strong applications. The recipients are: Associate Professor Kuang Hu, at UCL Institute of Ophthalmology. His project is...
An orthoptist report may well look like a piece of Japanese Shodo, however, it does in fact contain some extremely useful information. This piece will briefly explain some of the common brush strokes seen on a report. There is some...
A clinical trial led by NIHR Moorfields Clinical Research Facility will explore a new ‘light-touch’ treatment approach for patients with neovascular age-related macular degeneration (wet AMD) that could result in fewer injections and reduced number of clinic visits. Funded by...
A 48-year-old female has had multiple drug treatment for glaucoma and is still losing field of vision. How do you manage this over time? This patient is at high-risk for going blind and should be managed aggressively to protect remaining...